Schedules of Controlled Substances: Proposed Placement of Zaleplon into Schedule IV

[Federal Register Volume 64, Number 90 (Tuesday, May 11, 1999)]
[Corrections]
[Page 25405]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C9-11289]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration
[DEA-182P]

21 CFR Part 1308


Schedules of Controlled Substances: Proposed Placement of 
Zaleplon into Schedule IV

Correction

    In proposed rule document 99-11289, beginning on page 24094 in the 
issue of Wednesday May 5, 1999, make the following corrections:
    1. On page 24094, in the third column, beginning in the eighth line 
from the bottom, the sentence ``Zaleplon-related overdoes were also 
noted during the clinical trials'' is removed.
    2. On the same page, in the same column, in the fifth line from the 
bottom, ``overdoes'' should read ``overdoses''.
[FR Doc. C9-11289 Filed 5-10-99; 8:45 am]
BILLING CODE 1505-01-D